Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)

NCT04820673 · clinicaltrials.gov ↗

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Sarecycline

Sponsor

Almirall, S.A.